Telix Pharmaceuticals Ltd

For the period ended Dec 31, 2025. Filed Feb 20, 2026.

About this filing

The yearly report of a company based outside the US. It covers much of what a 10-K does, and may follow accounting rules other than US ones.

FY2025 · Filed Feb 20, 2026

TLX$9.63+2.2%Stored close · as of Nov 6, 2026

Contents

We have adopted a Code of Conduct applicable to all of our directors, officers, employees, consultants and contractors

to the Telix Group. Our Code of Conduct is publicly available on our website at www.telixpharma.com. We post on our

website all disclosures that are required by law, the ASX Listing Rules or the Nasdaq Listing Rules concerning any

amendments to, or waivers from, any provision of the Code of Conduct.

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.